Summary
Latest filing:
Jerome J. Dvonch is Chief Financial Officer of Sonoma Pharmaceuticals, Inc. (SNOA). 2 SEC Form 4 filings on record, most recently on 10 July 2026.
Trading Pattern
InsiderAlpha's records for Jerome J. Dvonch go back to 2026: 2 primary Form 4 filings, an average of 2.0 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
Other Insiders Active in the Same Sector
No other insider has filed at Jerome J. Dvonch's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Steven Leonard Chapman - $93.07M of NTRA open-market activity in the last 12 months
- SUVRETTA CAPITAL MANAGEMENT, LLC - $90.98M of MANE open-market activity in the last 12 months
- Pontifax Management 4 G.P. (2015) Ltd. - $84.98M of KROS open-market activity in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $83.13M of VOR open-market activity in the last 12 months
- Mark T. Bertolini - $82.60M of OSCR open-market activity in the last 12 months
- Frank Torti - $82.04M of ROIV open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Jerome J. Dvonch?
Jerome J. Dvonch is a corporate insider, tracked as Chief Financial Officer of Sonoma Pharmaceuticals, Inc. (SNOA). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Jerome J. Dvonch submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Where can I see all of Jerome J. Dvonch's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Jerome J. Dvonch and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial